Mabwell (Shanghai) Bioscience Co., Ltd. (SHA:688062)

SHA:688062 Revenue

Mabwell (Shanghai) Bioscience had revenue of 127.60M CNY in the quarter ending March 31, 2026, with 184.89% growth. This brings the company's revenue in the last twelve months to 745.32M, up 321.05% year-over-year. In the year 2025, Mabwell (Shanghai) Bioscience had annual revenue of 662.52M with 231.62% growth.

• Revenue (ttm): 745.32M
• Revenue Growth: +321.05%
• P/S Ratio: 21.35
• Revenue / Employee: 562.51K
• Employees: 1,325
• Market Cap: 15.91B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	662.52M	462.73M	231.62%
Dec 31, 2024	199.78M	71.95M	56.28%
Dec 31, 2023	127.84M	100.11M	361.03%
Dec 31, 2022	27.73M	11.50M	70.88%
Dec 31, 2021	16.23M	10.92M	206.03%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 10, 2026

Data Sources Report a data error